Zhitong Finance App News, Changfeng Pharmaceutical (02652.HK) issued an announcement. Recently, the company received a voluntary commitment from Dr. Liang Wenqing, the co-founder, chairman, executive director and CEO of the company, and Dr. Li Li, the company's co-founder, executive director and chief scientific officer, based on the long-term development prospects and long-term value of the group. According to the promise, the core management has voluntarily promised to extend the ban on company shares directly or indirectly beneficially owned by it for a further six months after the expiration of the original ban period. The sales ban will be extended from October 8, 2026 to April 7, 2027 (including the first and last two days).

Zhitong Finance App News, Changfeng Pharmaceutical (02652.HK) issued an announcement. Recently, the company received a voluntary commitment from Dr. Liang Wenqing, the co-founder, chairman, executive director and CEO of the company, and Dr. Li Li, the company's co-founder, executive director and chief scientific officer, based on the long-term development prospects and long-term value of the group. According to the promise, the core management has voluntarily promised to extend the ban on company shares directly or indirectly beneficially owned by it for a further six months after the expiration of the original ban period. The sales ban will be extended from October 8, 2026 to April 7, 2027 (including the first and last two days).